CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,724,890
- in 17 filings, $14.5M under 10b5-1 plans
Net −$14,724,890. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-11 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Sale | −2,500,000 | $49.52 | $123.8M | 30,993,708 |
| 2020-01-28 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Sale | −4,912,899 | $24.98 | $122.7M | 33,493,708 |
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Purchase | +250,000 | $20.00 | $5.0M | 1,675,000 |
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion | +18,908,945 | 20,583,945 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion | +15,524,350 | 36,108,295 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion | +2,007,740 | 38,116,035 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion | +290,572 | 38,406,607 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion · Series D Preferred Stock | −18,908,945 | 0 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion · Series E Preferred Stock | −15,524,350 | 0 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion · Series F Preferred Stock | −2,007,740 | 0 | ||
| 2019-07-01 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Conversion · Series F-1 Preferred Stock | −290,572 | 0 |
Page 1 of 1 · 11 trades